2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 29042365 | Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms. | 2017 Dec 28 | 1 |
| 2 | 24251790 | Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitors. | 2013 Nov | 1 |